Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin

Alimentary Pharmacology and Therapeutics

Volumn 32, Issue 7, 2010, Pages 831-839

  Fletcher, E H ^a,b   Johnston, D E ^b   Fisher, C R ^b   Koerner, R J ^b,c   Newton, J L ^a,d   Gray, C S ^a,b,e  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e Northern Deanery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM CHANNEL BLOCKING AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NAPROXEN; NITROVASODILATOR; NON ASPIRIN NON STEROIDAL ANTIINFLAMMATORY DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG; VASODILATOR AGENT;

ALCOHOL CONSUMPTION; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; DRUG USE; DUODENUM ULCER; EMBASE; ERADICATION THERAPY; ESOPHAGOGASTRODUODENOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMATEMESIS; HUMAN; INFECTION RISK; INFORMATION RETRIEVAL; LOGISTIC REGRESSION ANALYSIS; LOW DRUG DOSE; LUNG DISEASE; MAINTENANCE THERAPY; MEDLINE; MELENA; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SEROLOGY; STOMACH ULCER; SYSTEMATIC REVIEW; TREATMENT DURATION; UPPER GASTROINTESTINAL BLEEDING; UREA BREATH TEST;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; UPPER GASTROINTESTINAL TRACT;

EID: 77956417776     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2010.04415.x     Document Type: Article

References (28)

1. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br Med J 2002 324 : 71 86.
2. Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. Br Med J 1995 310 : 827 830.
3. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996 348 : 1329 1339.
4. Aalykke C, Lauritsen K. Epidemiology of NSAID-related gastroduodenal mucosal injury. Best Pract Res Clin Gastroenterol 2001 15 : 705 722.
5. Liu L, Turner JR, Yu Y, et al. Differential expression of EGFR during the early reparative phase of the gastric mucosa between young and aged rats. Am J Physiol 1998 275 : G943 50.
6. Cryer B, Redfern S, Goldschmiedt M, Lee E, Feldman M. Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans. Gastroenterology 1992 102 : 1118 1123.
7. Santolaria S, Lanas A, Benito R, Perez-Aisa MA, Montoro M, Sainz R. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. Aliment Pharmacol Ther 1999 13 : 1511 1518.
8. Hudson N, Balsitis M, Filipowicz F, Hawkey CJ. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993 34 : 748 751.
9. Feldman M, Cryer B, Mallat D, Go MF. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial. Am J Gastroenterol 2001 96 : 1751 1757.
10. Pilotto A, Leandro G, Di Mario F, et al. Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study. Dig Dis Sci 1997 42 : 586 591.
11. Liu N-J, Lee C-S, Tang J-H, et al. Outcomes of bleeding peptic ulcers: a prospective study. J Gastroenterol Hepatol 2008 23 : e340 7.
12. Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sainz R. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther 2002 16 : 779 786.
13. Piazuelo E, Fuentes J, Garcia-Gonzalez MA, Jimenez P, Lanas A. A case-control study of the association between polymorphisms of the endothelial nitric oxide synthase and glycoprotein IIIa genes and upper gastrointestinal bleeding in users of low-dose aspirin. Clin Ther 2008 30 : 121 130.
14. Ootani H, Iwakiri R, Shimoda R, et al. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J Gastroenterol 2006 41 : 41 6.
15. Nakayama M, Iwakiri R, Hara M, et al. Low-dose aspirin is a prominent cause of bleeding ulcers in patients who underwent emergency endoscopy. J Gastroenterol 2009 44 : 912 918.
16. Adamopoulos A, Efstathiou S, Tsioulos D, Tsami A, Mitromaras A, Mountokalakis T. Acute upper gastrointestinal bleeding: comparison between recent users and nonusers of nonsteroidal anti-inflammatory drugs. Endoscopy 2003 35 : 327 332.
17. Nakashima S, Arai S, Mizuno Y, et al. A clinical study of Japanese patients with ulcer induced by low-dose aspirin and other non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2005 21 (Suppl 2 60 6.
18. Tsesmeli NE, Kotsaftis PS, Savopoulos CG, et al. Incidence and etiology of acute non-malignant upper gastrointestinal bleeding in northern Greece. J Gastroenterol Hepatol 2007 22 : 1009 1013.
19. Ng TM, Fock KM, Khor JL, et al. Non-steroidal anti-inflammatory drugs, Helicobacter pylori and bleeding gastric ulcer. Aliment Pharmacol Ther 2000 14 : 203 209.
20. Akhtar AJ, Shaheen M. Upper gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs in African-American and Hispanic elderly patients. Ethn Dis 2003 13 : 528 533.
21. Pilotto A, Franceschi M, Leandro G, et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs. Aging Clin Exp Res 2003 15 : 494 499.
22. Pilotto A, Franceschi M, Leandro G, Longo MG, Perri F, Scarcelli C. Helicobacter pylori infection and the risk of gastro-duodenal damage in symptomatic elderly chronic low-dose aspirin users: effect of antisecretory drugs. Age Ageing 2004 33 : 402 404.
23. Serrano P, Lanas A, Arroyo MT, Ferreira IJ. Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases. Aliment Pharmacol Ther 2002 16 : 1945 1953.
24. Chan FKL, Chung SCS, Suen BY, et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001 344 : 967 973.
25. Dowlatshahi S, Ghofrani H, Togha M, Dowlatshahi S. Secondary prevention of upper gastrointestinal bleeding in low dose aspirin users infected with Helicobacter pylori. Med J Islam Repub Iran 2005 19 : 35 6.
26. Campbell CL, Smyth S, Montalescot G, Steinhubl S. Aspirin dose for the prevention of cardiovascular disease. JAMA 2007 297 : 2018 2024.
27. Kawai T, Yamagishi T, Goto S. Circadian variations of gastrointestinal mucosal damage detected with transnasal endoscopy in apparently healthy subjects treated with low-dose aspirin (ASA) for a short period. J Atheroscler Thromb 2009 16 : 155 163.
28. Lanas A, Scheiman J. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Curr Med Res Opin 2007 23 : 163 173.